Abstract
Set for success in the market, biotechnology could fulfil several objectives of the European Union, notably those relating to health, agriculture, the environment, technological development and general business competitiveness. However, several factors hinderthis knowledge-based technology from realizing its potential in Europe, as is measured by the usual indicators of competitiveness. The reasons are examined through a bottom-up approach, starting from the management of biotechnology research and moving towards business strategy and the role of consumers and regulators. Agricultural biotechnology in Europe is characterized by excellence in research but unattractiveness to investors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
